Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,805.10
-2.80 (-0.10%)
At close: Mar 30, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 350.32 billion as of March 30, 2026. Its market cap has increased by 9.17% in one year.
Market Cap
350.32B
Enterprise Value
343.38B
Revenue
52.02B
Ranking
n/a
PE Ratio
34.54
Stock Price
2,805.10
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 350.32B, an increase of 61,816.82%. That is a compound annual growth rate of 30.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 350.67B | 1.41% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 763.29B |
| Alkem Laboratories | 639.02B |
| Glenmark Pharmaceuticals | 612.52B |
| Laurus Labs | 544.61B |
| Ipca Laboratories | 402.37B |
| Emcure Pharmaceuticals | 313.33B |
| Gland Pharma | 284.06B |
| Wockhardt | 193.28B |